Toxicity of L-asparaginase drugs in acute lymphoblastic leukemia treatment
Currently no therapy of acute lymphoblastic leukemia is conceivable without L-asparaginase drugs, with its antileukemic effect by extracellular asparagine depletion, thus preventing its admission to leukemic cell. Besides high antitumor effect, L-asparaginase drugs have side and toxic effects, such...
Saved in:
| Main Author: | T. T. Valiev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2023-09-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/845 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
L-asparaginase: New about Well-Known Drug
by: Yuliya S. Korkina, et al.
Published: (2021-07-01) -
Optimization of native E. coli-asparaginase therapy in standard risk-group children with acute lymphoblastic leukemia treated by the ALL-MB 2002 protocol
by: M. Yu. Goroshkova, et al.
Published: (2022-11-01) -
Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance
by: Shih-Hsiang Chen
Published: (2015-10-01) -
Pharmacokinetics of Pegaspargase with a Limited Sampling Strategy for Asparaginase Activity Monitoring in Children with Acute Lymphoblastic Leukemia
by: Cristina Matteo, et al.
Published: (2025-07-01) -
Successful treatment of pancreatitis caused by L-asparaginase in clinical practice
by: Yu. S. Korkina, et al.
Published: (2024-01-01)